drugset / Trial / NCT03998761

Progesterone Versus Progesterone Plus Dydrogesterone in FET

NCT03998761

Completed 1364 enrolled My Duc Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Frozen embryo transfer (FET) has been increasing important in IVF. Progesterone is essential for the endometrial secretory transformation, establishment and maintenance of pregnancy. In FET, as there is neither corpus luteum nor the support of hCG, the role of progesterone is even more important to ensure a sufficient luteal phase support. Vaginal progesterone has been the most common preparation for luteal support in fresh embryo transfer during IVF because of their ease of use and comparable effectiveness compared to intramuscular progesterone. Recently, there was evidence of the considerable variation in uptake, absorption and metabolism of intra-vaginal micronized progesterone. Dydrogesterone alone has described to have similar effectiveness, safety and tolerability prolfiles for luteal phase support compared to vaginal progesterone in luteal phase support for fresh embryo transfer. This prospective study compares the effectiveness of micronized progesterone versus micronized progesterone plus dydrogesterone for luteal phase support in FET.

Timeline

Start
2019-06-26
Primary completion
2021-01-05
Completion
2021-01-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dydrogesterone Other / unclassified 10 mg
Comparator Progesterone Other / unclassified 400 mg

Indications